Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW)

CUSIP: G0705H111

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / *W EXP 10/01/202
Total 13F shares
6,320,063
Share change
+5,516,742
Total reported value
$1,364,295
Price per share
$0.20
Number of holders
31
Value change
+$1,199,614
Number of buys
30

Quarterly Holders Quick Answers

What is CUSIP G0705H111?
CUSIP G0705H111 identifies BDMDW - Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) as of Q4 2024

As of 31 Dec 2024, Baird Medical Investment Holdings Ltd - *W EXP 10/01/202 (BDMDW) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,320,063 shares. The largest 10 holders included GRITSTONE ASSET MANAGEMENT LLC, Sculptor Capital LP, Calamos Advisors LLC, Kepos Capital LP, CLEAR STREET LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Davidson Kempner Capital Management LP, Shaolin Capital Management LLC, Linden Advisors LP, and Sandia Investment Management LP. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.